Committed to developing treatments for orphan diseases
Laurent Pharmaceuticals is an orphan drug company with a clinical development program in cystic fibrosis.
Laurent Pharmaceuticals to participate at the NACFC 2018, October 18th-20th 2018, Denver, Colorado, USA
Laurent Pharmaceuticals to participate at RESI NYC 2018, November 5th 2018, New York City, USA
Laurent Pharmaceuticals reaches agreement with US Cystic Fibrosis Foundation to increase Development Award to $US 5M
Laurent Pharmaceuticals Receives FDA and Health Canada Clearance to Initiate APPLAUD Phase 2 Clinical Study of LAU-7b for the Treatment of Cystic Fibrosis